Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

90.0%

+3.5% vs industry average

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

33%

3 of 9 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A
10(83.3%)
Phase 2
1(8.3%)
Phase 3
1(8.3%)
12Total
N/A(10)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)

Showing 12 of 12 trials
NCT06834906Not ApplicableRecruiting

Usability User Testing of the Easy-EyeFM AI Platform

Role: collaborator

NCT02852330Not ApplicableCompleted

Intracochlear Potentials: Volta Study

Role: collaborator

NCT01829295Phase 3Completed

Methotrexate and Mycophenolate Mofetil for UVEITIS

Role: collaborator

NCT03106181Not ApplicableCompleted

A Comparison of Cataract Surgery Alone and Cataract Surgery With iStent

Role: lead

NCT02746172Not ApplicableCompleted

Clinical Metrics for Assessing Cochlear Implant Recipient MAPs

Role: collaborator

NCT02794623Not ApplicableCompleted

Tinnitus Suppression for Cochlear Implant Recipients

Role: collaborator

NCT02879539Not ApplicableCompleted

Cochlear Implant Low Power Strategy

Role: collaborator

NCT02905305Not ApplicableCompleted

Cochlear Implant With Anti-Inflammatory Agent

Role: collaborator

NCT02765386Not ApplicableTerminated

Optimisation of Hybrid Fittings for Cochlear Implant Recipients

Role: collaborator

NCT02671032Not ApplicableCompleted

CHANGE Feasibility Study

Role: collaborator

NCT04051697Not ApplicableUnknown

The SEA CHANGE Study: A Self Management Intervention for Head and Neck Cancer Survivors

Role: collaborator

NCT01442623Phase 2Completed

Conventional Versus Virtual Reality Based Vestibular Rehabilitation

Role: collaborator

All 12 trials loaded